Literature DB >> 6154763

Recognition of viral glycoproteins by influenza A-specific cross-reactive cytolytic T lymphocytes.

U H Koszinowski, H Allen, M J Gething, M D Waterfield, H D Klenk.   

Abstract

Two populations of cytolytic T lymphocytes (CTL) generated after influenza A virus infection can be distinguished into one with specificity for the sensitizing hemagglutinin type and a second with cross-reactivity for antigens induced by other type-A influenza viruses. The molecules carrying the antigenic determinants recognized by the cross-reactive CTL were studied. In L-929 cells abortively infected with fowl plague virus, matrix (M) protein synthesis is specifically inhibited, whereas the envelope glycoproteins, hemagglutinin and neuraminidase, are synthesized and incorporated into the plasma membrane. These target cells were lysed by cross-reactive CTL. The envelope proteins of type A/Victoria virus were separated from the other virion components and reconstituted into lipid vesicles that lacked M protein that subsequently were used to prepare artificial target cells. Target-cell formation with vesicles was achieved by addition of fusion-active Sendai virus. These artificial target cells were also susceptible to lysis by cross-reactive CTL. In contrast to previous observations that suggested that the M protein of influenza viruses is recognized by these effector cells, we present evidence that the antigencic determinants induced by the viral glycoproteins are recognized.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6154763      PMCID: PMC2185822          DOI: 10.1084/jem.151.4.945

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  38 in total

1.  Changes in the surface of virus-infected cells recognized by cytotoxic T cells. II. A requirement for glycoprotein synthesis in virus-infected target cells.

Authors:  D C Jackson; G L Ada; A J Hapel; M B Dunlop
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

2.  Cytotoxic T cells kill influenza virus infected cells but do not distinguish between serologically distinct type A viruses.

Authors:  H J Zweerink; S A Courtneidge; J J Skehel; M J Crumpton; B A Askonas
Journal:  Nature       Date:  1977-05-26       Impact factor: 49.962

3.  Cytotoxic T cells specific for influenza virus-infected target cells.

Authors:  K L Yap; G L Ada
Journal:  Immunology       Date:  1977-02       Impact factor: 7.397

4.  Heterogeneity of the cytotoxic response of thymus-derived lymphocytes after immunization with influenza viruses.

Authors:  P C Doherty; R B Effros; J Bennink
Journal:  Proc Natl Acad Sci U S A       Date:  1977-03       Impact factor: 11.205

5.  The antigen specificity of thymus-derived helper cells.

Authors:  M Hoffmann; J W Kappler
Journal:  J Immunol       Date:  1972-01       Impact factor: 5.422

6.  Cell surface proteins of NIL1 hamster fibroblasts labeled by a galactose oxidase, tritiated borohydride method.

Authors:  D R Critchley
Journal:  Cell       Date:  1974-10       Impact factor: 41.582

7.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

8.  Studies on the primary structure of the influenza virus hemagglutinin.

Authors:  J J Skehel; M D Waterfield
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

9.  Immunologic recognition of influenza virus-infected cells. II. Expression of influenza A matrix protein on the infected cell surface and its role in recognition by cross-reactive cytotoxic T cells.

Authors:  T J Braciale
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

10.  Antibody to influenza virus matrix protein detects a common antigen on the surface of cells infected with type A influenza viruses.

Authors:  W E Biddison; P C Doherty; R G Webster
Journal:  J Exp Med       Date:  1977-09-01       Impact factor: 14.307

View more
  23 in total

1.  N protein is the predominant antigen recognized by vesicular stomatitis virus-specific cytotoxic T cells.

Authors:  L Puddington; M J Bevan; J K Rose; L Lefrançois
Journal:  J Virol       Date:  1986-11       Impact factor: 5.103

Review 2.  Recognition of influenza virus proteins by cytotoxic T lymphocytes.

Authors:  A R Townsend
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

3.  Evidence for two T-helper populations with distinct specificity in the humoral response to influenza A viruses.

Authors:  D B Thomas; C J Hackett; B A Askonas
Journal:  Immunology       Date:  1982-11       Impact factor: 7.397

4.  Surface expression of a nonstructural antigen on influenza A virus-infected cells.

Authors:  M W Shaw; E W Lamon; R W Compans
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

5.  Selective dansylation of M protein within intact influenza virions.

Authors:  B H Robertson; J C Bennett; R W Compans
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

6.  H-2 and viral haemagglutinin expression by influenza-infected cells; the proteins are close but do not cocap.

Authors:  C J Hackett; B A Askonas
Journal:  Immunology       Date:  1982-03       Impact factor: 7.397

7.  Influenza virus hemagglutinin containing an altered hydrophobic carboxy terminus accumulates intracellularly.

Authors:  M M Sveda; L J Markoff; C J Lai
Journal:  J Virol       Date:  1984-01       Impact factor: 5.103

8.  Stimulation of cytotoxic T cells by liposomes containing influenza virus or its components.

Authors:  C J Hackett; P M Taylor; B A Askonas
Journal:  Immunology       Date:  1983-06       Impact factor: 7.397

9.  Cell-mediated immunity to herpes simplex virus: specificity of cytotoxic T cells.

Authors:  M J Lawman; R J Courtney; R Eberle; P A Schaffer; M K O'Hara; B T Rouse
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

10.  Class I H-2d-restricted cytotoxic T lymphocytes recognize the neuraminidase glycoprotein of influenza virus subtype N1.

Authors:  M Wysocka; C J Hackett
Journal:  J Virol       Date:  1990-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.